Difenoksin
Изглед
| Klinički podaci | |
|---|---|
| Drugs.com | Monografija |
| Način primene | Oralno |
| Farmakokinetički podaci | |
| Poluvreme eliminacije | 7,24 h |
| Izlučivanje | Renalno, fekalno |
| Identifikatori | |
| CAS broj | 28782-42-5 |
| ATC kod | A07DA04 (WHO) |
| PubChem | CID 34328 |
| DrugBank | DB01501 |
| ChemSpider | 31620 |
| KEGG | C07871 |
| ChEBI | CHEBI:4534 |
| ChEMBL | CHEMBL1201321 |
| Hemijski podaci | |
| Formula | C28H28N2O2 |
| Molarna masa | 424,534 |
| |
| |
Difenoksin je organsko jedinjenje, koje sadrži 28 atoma ugljenika i ima molekulsku masu od 424,534 Da.[1][2][3]
Osobine
[уреди | уреди извор]| Osobina | Vrednost |
|---|---|
| Broj akceptora vodonika | 4 |
| Broj donora vodonika | 1 |
| Broj rotacionih veza | 7 |
| Particioni koeficijent[4] (ALogP) | 2,1 |
| Rastvorljivost[5] (logS, log(mol/L)) | -7,5 |
| Polarna površina[6] (PSA, Å2) | 64,3 |
Reference
[уреди | уреди извор]- ^ De Luca, Anthony, and Ian M. Coupar. Difenoxin and loperamide: studies on possible mechanisms of intestinal antisecretory action. De Luca, A.; Coupar, I. M. (1993). „Difenoxin and loperamide: Studies on possible mechanisms of intestinal antisecretory action”. Naunyn-Schmiedeberg's Archives of Pharmacology. 347 (2): 231—237. PMID 8386327. doi:10.1007/BF00169273.: .
- ^ Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. (2011). „DrugBank 3.0: A comprehensive resource for 'omics' research on drugs”. Nucleic Acids Research. 39 (Database issue): D1035—41. PMC 3013709
. PMID 21059682. doi:10.1093/nar/gkq1126.
- ^ Wishart, D. S.; Knox, C.; Guo, A. C.; Cheng, D.; Shrivastava, S.; Tzur, D.; Gautam, B.; Hassanali, M. (2008). „DrugBank: A knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Research. 36 (Database issue): D901—6. PMC 2238889
. PMID 18048412. doi:10.1093/nar/gkm958.
- ^ Ghose, Arup K.; Viswanadhan, Vellarkad N.; Wendoloski, John J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods”. The Journal of Physical Chemistry A. 102 (21): 3762—3772. Bibcode:1998JPCA..102.3762G. doi:10.1021/jp980230o.
- ^ Tetko, I. V.; Tanchuk, V. Y.; Kasheva, T. N.; Villa, A. E. (2001). „Estimation of aqueous solubility of chemical compounds using E-state indices”. Journal of Chemical Information and Computer Sciences. 41 (6): 1488—1493. PMID 11749573. doi:10.1021/ci000392t.
- ^ Ertl, P.; Rohde, B.; Selzer, P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties”. Journal of Medicinal Chemistry. 43 (20): 3714—3717. PMID 11020286. doi:10.1021/jm000942e.
Literatura
[уреди | уреди извор]- Hardman JG, Limbird LE, Gilman AG (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10. изд.). New York: McGraw-Hill. ISBN 0071354697. doi:10.1036/0071422803.
- Thomas L. Lemke; David A. Williams, ур. (2007). Foye's Principles of Medicinal Chemistry (6. изд.). Baltimore: Lippincott Willams & Wilkins. ISBN 0781768799.
Spoljašnje veze
[уреди | уреди извор]
| Molimo Vas, obratite pažnju na važno upozorenje u vezi sa temama iz oblasti medicine (zdravlja). |